Author:
Hellard M.,Scott N.,Sacks-Davis R.,Pedrana A.
Reference20 articles.
1. Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe;Fraser;J Hepatol,2018
2. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence;Turner;Addiction,2011
3. Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe;Marshall;Lancet Gastroenterol Hepatol,2017
4. Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses;Lazarus;Int J Drug Policy,2017
5. Wong E, Pedrana A, Draper B, Gold J, Richmond J, Stoove M, Doyle J, Thompson A, Hellard M, on behalf of the EC Partnership investigator team. Models of Care – exploring different clinical models of care for hepatitis C treatment scale up. AVHEC, Cairns 2017.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献